Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 6.98 -0.25 (-3.45%) Market Cap: 1.03 Bil Enterprise Value: 1.29 Bil PE Ratio: 0 PB Ratio: 4.89 GF Score: 56/100

Q1 2026 Maravai LifeSciences Holdings Inc Earnings Call Transcript

May 07, 2026 / 09:00PM GMT
Release Date Price: $3.94
Operator

Hello and welcome everyone joining today's Maravai LifeSciences Q1 2026 earnings call. (Operator Instructions) Please note this call is being recorded. We are standing by if you should need any assistance.

It is now my pleasure to turn the meeting over to Deb Hart, Head of Investor Relations. Please go ahead.

Debra Hart
Maravai LifeSciences Holdings Inc - Head of Investor Relations

Good afternoon, everyone. Thanks for joining us for our first-quarter 2026 earnings call. The press release and slides accompanying today's call are posted on our website and available at investors.maravai.com.

As you can see from the agenda on slide 2, our CEO, Bernd Brust, will provide a business update; and our CFO, Raj Asarpota, will review our financial results. Dr. Chanfeng Zhao, our Chief Scientific Officer, will join us for the Q&A session.

Management will make forward-looking statements and refer to GAAP and non-GAAP financial measures during today's call. It's possible that actual results could differ from expectations. We refer you to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot